Definitive chemoradiation for oligometastatic esophageal cancer patients. PIONEER: A multicenter, open-label, randomized phase II trial of second-line apatinib plus chemotherapy versus chemotherapy ...
The recently reported SUPREMO trial evaluated chest wall radiotherapy after mastectomy in patients with intermediate-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results